Table 4.
Characteristics of Smokers With Chronic Pancreatitis
| Category | Smoking Cessation Specialist and QuitWorks (n=14) |
QuitWorks only (n=13) |
|---|---|---|
| Age, y | 49.1 ± 7.9 | 47.8 ± 5.4 |
| Sex (p<0.03) | 1 Male (7.7%) 13 Female (92.3%) |
6 Male (46.2%) 7 Female (53.8%) |
| Pack-years (years) | 29.4 ± 16.4 | 21.9 ± 11.8 |
| Baseline ppd | 1.1 ± 0.52 | 1.0 ± 0.39 |
| 18-month ppd | 0.95 ± 0.55 | 0.73 ± 0.52 |
| Baseline CO level (parts per million) | 25.5 ± 12.1 | NA |
| 18-month CO level (parts per million) | 28.3 ± 18.3 | NA |
| Baseline COHb (%) | 4.7 ± 1.9 | NA |
| 18-month COHb (%) | 5.5 ± 3.1 | NA |
| Smoking cessation product | Nicotine Patch (35.7%) Electronic Cigarette (28.6%) Varenicline (7.1%) |
Nicotine Patch (46.2%) Electronic Cigarette (15.4%) Varenicline (15.4%) |
| Concomitant drug use | Marijuana (21.4%) | Marijuana (23.1%) |
| Fagerström nicotine tolerance questionnaire | Low Risk (28.6%) Medium Risk (35.7%) High Risk (35.7%) |
Low Risk (38.5%) Medium Risk (30.8%) High Risk (30.8%) |
| Quit rate at 6 months | 0% | 0% |
| Quit rate at 12 months | 7.10% | 0% |
| Quit rate at 18 months | 0% | 0% |
ppd indicates packs per day; CO, carbon monoxide; COHb, carboxyhemoglobin